What is the recommended intravenous (IV) dose of Cefuroxime (Cefuroxime axetil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended intravenous (IV) dose of Cefuroxime is 1.5 g every 8 h. This dosage is based on the guidelines for the diagnosis and management of complicated intra-abdominal infection in adults and children, as outlined in the Clinical Infectious Diseases journal 1.

Key Considerations

  • The dosage is applicable for adults with normal renal and hepatic function.
  • The guidelines provide a range of antibiotic dosages for empiric treatment of complicated intra-abdominal infection, including Cefuroxime.
  • It is essential to note that dosage adjustments may be necessary for patients with renal impairment, but this information is not provided in the given study.

Antibiotic Dosage Comparison

  • The study provides a comprehensive list of initial intravenous adult dosages of antibiotics for empiric treatment of complicated intra-abdominal infection, including:
    • Cephalosporins: Cefazolin (1–2 g every 8 h), Cefepime (2 g every 8–12 h), Cefotaxime (1–2 g every 6–8 h), and Ceftriaxone (1–2 g every 12–24 h)
    • Carbapenems: Doripenem (500 mg every 8 h), Ertapenem (1 g every 24 h), Imipenem/cilistatin (500 mg every 6 h or 1 g every 8 h), and Meropenem (1 g every 8 h)
    • Fluoroquinolones: Ciprofloxacin (400 mg every 12 h), Levofloxacin (750 mg every 24 h), and Moxifloxacin (400 mg every 24 h)

Clinical Context

  • Cefuroxime is a second-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis.
  • It has good activity against many gram-positive and gram-negative bacteria, including some beta-lactamase producing strains, making it useful for respiratory, urinary tract, skin, and soft tissue infections.
  • The IV formulation provides rapid therapeutic blood levels and is particularly valuable when oral administration is not feasible or when treating more severe infections.

From the FDA Drug Label

5 gram dose every 8 hours is recommended. In bone and joint infections, a 1. 5-gram dose every 8 hours is recommended. In life-threatening infections or infections due to less susceptible organisms, 1. 5 grams every 6 hours may be required. In bacterial meningitis, the dosage should not exceed 3 grams every 8 hours.

The recommended intravenous (IV) dose of Cefuroxime is:

  • 5 grams every 8 hours for most infections
  • 1.5 grams every 8 hours for bone and joint infections
  • 1.5 grams every 6 hours for life-threatening infections or infections due to less susceptible organisms
  • Not to exceed 3 grams every 8 hours for bacterial meningitis 2

From the Research

Recommended Intravenous (IV) Dose of Cefuroxime

The recommended IV dose of Cefuroxime varies depending on the specific condition being treated and the patient population.

  • For healthy young volunteers, a dosage regimen of 750 mg every 12 hours is recommended for treating Streptococcus pneumoniae 3.
  • For patients with severe renal insufficiency, a dose of 750 mg twice daily or 750 mg once daily is recommended, depending on the degree of renal impairment 4.
  • In critically ill patients undergoing continuous venovenous hemofiltration, a maintenance dose of 3000 mg cefuroxime infused over 24 hours is predicted to provide an optimal steady-state plasma concentration 5.
  • For infants and children with suspected bacterial pneumonia, a dose of 75 mg/kg/day divided every 8 hours IV or IM is recommended 6.

Special Considerations

  • The volume of distribution and clearance of cefuroxime may vary depending on the patient population and renal function 3, 4, 5.
  • Cefuroxime has been shown to be safe and effective in various patient populations, including infants and children 6 and patients with severe renal insufficiency 4.
  • Toxicological studies have demonstrated that cefuroxime is well-tolerated at high doses, with no serious toxic effects observed 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.